Can a daily pill slow the visible signs of aging?

NCT ID NCT07827651

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 ยท Last updated Sep 18, 2026

Summary

Researchers are testing whether a daily oral supplement regimen improves skin, hair, sleep, energy, cognition and sexual wellbeing in healthy adults aged 35 to 65. Participants take either the active supplement or a placebo for 12 weeks. The study measures skin elasticity, firmness, hydration and wrinkles, plus hair density and thickness, sleep quality, vitality and cognitive speed. Blood samples are also analyzed for biological aging markers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a daily oral supplement regimen of omega gel capsules plus a collagen complex powder
What this could lead to
If it works, this could point toward an easy daily supplement that supports skin, hair, sleep and energy as people age.
What could go wrong
This is a small, 12-week study of 64 healthy adults, so any benefits may be modest or fade, and supplements often fail to show effects beyond placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

64 people

The number who actually took part.

Started

Dec 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy adults aged 35 to 65 years (30% male : 70% female desired) * In generally good health, as determined by medical history questionnaire * Free from excessive hair, tattoos, dermatitis or scars on the test areas; males must attend each visit clean shaven, having shaved the day before the appointment * Able to read, understand and sign an informed consent agreement * Able to communicate well with study personnel and comply with study requirements * Hair at least 3 cm long, with no intention of substantial change to hair style * Participants on medicinal contraception: stable method for at least 3 months prior to baseline and willing not to change for the study duration * Women of childbearing potential: willing to use a reliable method of contraception * Participants on hormone replacement therapy: stable HRT for at least 6 months prior to baseline and willing not to change * Willing not to change regular food habits or commence any diet or nutritional change * Willing to refrain from taking any new dietary supplements other than study products * Willing to maintain usual lifestyle habits including exercise regimes * Willing to avoid medicated shampoo and conditioner * Willing to refrain from dermato-aesthetic facial procedures * Willing to refrain from chemical hair styling procedures (colour treatments permitted) * Willing to avoid excessive natural sunlight and other avoidable UV sources * Willing to remove facial piercings, earrings or jewellery prior to imaging * Willing to consent to use of their images by the Sponsor * Willing to have photographs taken to record any significant reactions * Willing to adhere to all study restrictions and requirements Exclusion Criteria: * \- Pregnant, breastfeeding, or of childbearing potential and not using reliable contraception * Consumed any food or health supplements (including vitamins, creatine, omegas, collagen) within the 3 months prior to baseline * Known allergy or hypersensitivity to any study product ingredient (products contain fish and coconut ingredients) * Known allergy or hypersensitivity to any dietary supplements * Any systemic condition (acute or chronic) or skin disorder including eczema, psoriasis, acne or diabetes (inactive skin disease for at least 6 months prior to baseline may be accepted at the Project Manager's discretion) * History of skin cancer with remission period below 5 years * Asthma or other chronic respiratory condition requiring therapy within the last 6 months * Any other systemic disease or medical or skin condition which in the opinion of the Project Manager, Study Doctor or Sponsor would affect ability to complete the study * Diagnosis of high cholesterol (current or previous) * Current treatment with cholesterol lowering medication * Family history of high cholesterol (first degree relative) * Diagnosis of ischaemic heart disease (current or previous) * Diagnosis of peripheral vascular disease or intermittent claudication * Diagnosis of stroke (current or previous) * Treatment (oral or topical) with tretinoin, isotretinoin or corticosteroids within the 6 months prior to baseline * Systemic steroids or anti-inflammatory treatments within the 6 months prior to baseline * Medications which may affect sampling or analysis, including metformin, anticoagulants, biological therapies, immunosuppressive or immunomodulating medication, chemotherapy, cytokine or anti-cytokine therapy * Surgical or non-surgical dermato-aesthetic facial procedures within the 6 months prior to baseline * Facial surgery (excluding dental) within the previous 6 months * Diagnosis of facial nerve damage * False eyelashes of any type on assessment days * Refusal to remove eyebrow make-up * Facial or ear piercings that cannot be removed for assessments * Low protein diet * Vegetarian or vegan diet (study products contain marine collagen and bovine gelatine) * Average alcohol consumption greater than 14 units per week * Night shift workers or irregular working hours interfering with regular sleep pattern * Intention to commence smoking cessation activities or alternative nicotine products during the study * Medically diagnosed insomnia * Active medically diagnosed alopecia or previous history * History of or high risk of blood borne infection (HIV, hepatitis B or C, AIDS) * History of problematic blood collections or negative experience during surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biological ageing are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eurofins Product Testing Services Ltd (Eurofins Alba)

    Edinburgh, EH1 3RH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.